Delivered for 70+ infectious disease, microbiology and women’s health firms
With decades of experience guiding programs through the complex landscape of infectious disease market approval, our team knows the terrain and how to navigate it. We’ve partnered with more than 70 organizations advancing diagnostics and therapeutics for viral, bacterial, and fungal pathogens—bringing the precision, speed, and regulatory acumen these programs demand. From rapid antigen and molecular assays to complex microbiology platforms, we anticipate challenges before they arise and chart a clear course from strategy and planning through regulatory approval. With a proven record of flawless execution, we deliver the expertise and guidance needed to bring infectious disease innovations confidently to market.
Syndromic/targeted molecular projects
Covering multiple diseases including respiratory, STI, TB, GI, ME, UTI
Antimicrobial susceptibility projects
Using both rapid/direct from PBC and conventional AST or chromogenic media
Direct from whole blood/sepsis projects
Optimized to use central laboratory and Point-of-Care platforms
WHERE WE SHINE
Markets
The MDC team has worked with IVD manufacturers across a wide range of therapeutic areas helping to bring diagnostics innovation to market where it’s needed most to impact patients.
Infectious Diseases & Microbiology
Partnered with 40+ infectious disease, microbiology and women's health firms
Clinical Chemistry & Hematology
CLIA-waived, PoC & OTC
Experts after 60+ projects in point of care and over-the-counter testing